Volume 86, Issue 1, Pages 210-211 (July 2014) Rituximab in pure red-cell aplasia secondary to anti-erythropoietin antibodies Thibault Comont, Barbara Bournet, Nicole Casadevall, Dominique Chauveau, Stanislas Faguer Kidney International Volume 86, Issue 1, Pages 210-211 (July 2014) DOI: 10.1038/ki.2014.144 Copyright © 2014 International Society of Nephrology Terms and Conditions
Figure 1 Hemoglobin level and requirement for red blood cell transfusion in a patient with rHu-EPO-related PRCA successfully treated by rituximab. Ab, anti-rHu-EPO antibody; EPO, erythropoietin; Hb, hemoglobin; PRBC, pure red blood cell; PRCA, pure red-cell aplasia. Kidney International 2014 86, 210-211DOI: (10.1038/ki.2014.144) Copyright © 2014 International Society of Nephrology Terms and Conditions